Stay up to date with company announcements and reports

83bar executive Kate Hermans to moderate panel at SCOPE Summit 2020

January 28, 2020
  • Ms. Hermans, Chief Business Officer for Pharma, will exchanges views on measuring patient empowerment in clinical trial recruitment
  • Panel discussion will cover vendor performance metrics and KPIs, as part of outsourcing and strategic partnerships in clinical trials
  • Insights based on 83bar experience using 4-step Patient Activation process in clinical trial recruitment

Kate Hermans, Chief Business Officer for Pharma at 83bar LLC, will moderate a panel session on patient empowerment at the 11th annual SCOPE Summit 2020 February 18-21 in Orlando, FL.

Joining Ms. Hermans at the SCOPE Summit from 83bar will be Evan Bingen, Director of Business Development.

83bar has developed a fully integrated digital health technology and concierge platform that enables individualized patient activation at scale. The use of the platform for clinical trial recruitment has shown meaningful results for study sponsors, investigator sites, and patients.

The topics of the panel moderated by Ms. Hermans will include:
  • How effective are your KPIs for measuring vendor performance and quality?
  • What is your strategy for establishing KPIs and metrics?
  • What are the key areas that should be evaluated for vendor performance and quality?
  • Innovative approaches to drive patient empowerment in the clinical trial process.
  • Improving the quality of the patient experience and its real-world implications for development of new therapies and medical devices

The group moderated by Ms. Hermans is an interactive, guided discussion on some of the key issues presented in earlier sessions. Delegates will join a table of interest and become an active part of the discussion at hand. They will bring their own pharma, biotech, CRO, site, hospital or patient perspectives. They will share examples from their work and vet new ideas among peers.



Celebrating its eleventh year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the four days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy and Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Resource Management, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence, Post-Marketing Studies, Observational Research, Accessing and Generating RWD, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, Clinical Biomarkers and Biospecimens, and Central Lab Solutions, and Medical Device Clinical Trial Operations and Regulations.

SCOPE attracted more than 2,000 leaders in clinical operations and research in 2019. Each of its conference tracks featured best practice case studies relevant to clinical operations experts and those new to the field.

More information at

About 83bar, LLC

83bar, LLC, headquartered in Austin, Texas, is the leading patient activation marketing agency. 83bar has developed a system that has been implemented by more than three dozen name brands in health, medical, technology, and devices.

The company has a database of more than one million patient engagements over the past five years. Its four-step activation process is a system integrated to LOCATE prospective patients through risk assessment and health surveys; EDUCATE them to offer solutions and help them make informed decisions; NAVIGATE patients to action by appointment scheduling or service fulfillment; and through comprehensive follow-up, convert these patients to ADVOCATE on behalf of improved treatment and health care.

Contact at